PRESS RELEASE published on 04/04/2025 at 00:00, 8 months 2 days ago Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025 Onco-Innovations Limited's subsidiary, Inka Health Corp., completes analytical work for AstraZeneca Canada, showcasing advancements in pharmaceutical evidence generation and real-world data use Real-world Data Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Pharmaceutical Evidence Generation
BRIEF published on 03/26/2025 at 23:05, 8 months 10 days ago Study Explores Low Toxicity of Onco-Innovations' PNKP Technology Cancer Treatment Radiation Therapy Onco-Innovations PNKP Technology Low Toxicity
BRIEF published on 03/26/2025 at 23:05, 8 months 10 days ago Une étude explore la faible toxicité de la technologie PNKP d'Onco-Innovations Traitement Du Cancer Radiothérapie Onco-Innovations Technologie PNKP Faible Toxicité
PRESS RELEASE published on 03/26/2025 at 23:00, 8 months 10 days ago Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile Onco-Innovations Limited announces successful nanoparticle formulation of PNKP Compound with low toxicity and effective cancer cell targeting in mice, promising safer treatment options Cancer Treatment Onco-Innovations Limited Nanoparticle Formulation PNKP Compound Low Toxicity
BRIEF published on 03/25/2025 at 22:05, 8 months 11 days ago Onco-Innovations Extends Marketing Partnership with MCS Digital Advertising Onco-Innovations Marketing Extension MCS Partnership CAD 600,000 Budget
BRIEF published on 03/25/2025 at 22:05, 8 months 11 days ago Onco-Innovations étend son partenariat marketing avec MCS Publicité Numérique Onco-Innovations Extension Marketing Partenariat MCS Budget De 600 000 $ CA
PRESS RELEASE published on 03/25/2025 at 22:00, 8 months 11 days ago Onco-Innovations Extends Marketing Program Onco-Innovations Limited extends engagement with MCS Market Communication Service GmbH for online marketing services until May 31, 2025. Company aims to revolutionize cancer treatment with patented technology Patented Technology Cancer Treatment Onco-Innovations Limited MCS Market Communication Service GmbH Online Marketing Services
BRIEF published on 03/24/2025 at 23:05, 8 months 12 days ago Onco-Innovations Updates Proceeds Utilization Strategy Investor Relations Equity Financing Research And Development Onco-Innovations Proceeds Update
BRIEF published on 03/24/2025 at 23:05, 8 months 12 days ago Onco-Innovations met à jour sa stratégie d'utilisation des bénéfices Recherche Et Développement Relations Avec Les Investisseurs Financement Par Actions Onco-Innovations Mise À Jour Des Recettes
PRESS RELEASE published on 03/24/2025 at 23:00, 8 months 12 days ago Onco-Innovations Provides Update on Use of Proceeds Onco-Innovations Limited provides an update on the use of proceeds from its Prospectus, focusing on investor relations activities and increased research and development spending for cancer treatments Investor Relations Research And Development Cancer Treatment Onco-Innovations Limited Use Of Proceeds
Published on 12/06/2025 at 00:25, 11 minutes ago GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 36 minutes ago Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 1 hour 6 minutes ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 21:45, 2 hours 51 minutes ago When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 22:15, 2 hours 20 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 2 hours 24 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 5 hours 38 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 6 hours 21 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 1 hour 36 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 36 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 36 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 1 hour 36 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 7 hours 18 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible